NO20025930L - Fettsyreanaloger for behandling av cancer - Google Patents

Fettsyreanaloger for behandling av cancer

Info

Publication number
NO20025930L
NO20025930L NO20025930A NO20025930A NO20025930L NO 20025930 L NO20025930 L NO 20025930L NO 20025930 A NO20025930 A NO 20025930A NO 20025930 A NO20025930 A NO 20025930A NO 20025930 L NO20025930 L NO 20025930L
Authority
NO
Norway
Prior art keywords
sub
alkyl
fatty acid
treatment
cancer
Prior art date
Application number
NO20025930A
Other languages
English (en)
Other versions
NO20025930D0 (no
NO324634B1 (no
Inventor
Rolf Berge
Original Assignee
Thia Medica As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thia Medica As filed Critical Thia Medica As
Priority to NO20025930A priority Critical patent/NO324634B1/no
Publication of NO20025930D0 publication Critical patent/NO20025930D0/no
Publication of NO20025930L publication Critical patent/NO20025930L/no
Publication of NO324634B1 publication Critical patent/NO324634B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20025930A 2000-07-13 2002-12-11 Fettsyreanaloger for behandling av cancer NO324634B1 (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO20025930A NO324634B1 (no) 2000-07-13 2002-12-11 Fettsyreanaloger for behandling av cancer

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NO20003591A NO20003591L (no) 2000-07-13 2000-07-13 Fettsyreanaloger for behandling av kreft
PCT/NO2001/000301 WO2002003983A1 (en) 2000-07-13 2001-07-13 Fatty acid analogues for the treatment of cancer
NO20025930A NO324634B1 (no) 2000-07-13 2002-12-11 Fettsyreanaloger for behandling av cancer

Publications (3)

Publication Number Publication Date
NO20025930D0 NO20025930D0 (no) 2002-12-11
NO20025930L true NO20025930L (no) 2003-01-13
NO324634B1 NO324634B1 (no) 2007-11-26

Family

ID=19911376

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20003591A NO20003591L (no) 2000-07-13 2000-07-13 Fettsyreanaloger for behandling av kreft
NO20025930A NO324634B1 (no) 2000-07-13 2002-12-11 Fettsyreanaloger for behandling av cancer

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO20003591A NO20003591L (no) 2000-07-13 2000-07-13 Fettsyreanaloger for behandling av kreft

Country Status (18)

Country Link
US (1) US7378443B2 (no)
EP (1) EP1313463B1 (no)
JP (1) JP2004502732A (no)
KR (2) KR100861428B1 (no)
CN (1) CN100569228C (no)
AT (1) ATE320802T1 (no)
AU (2) AU7286001A (no)
BR (1) BR0112399A (no)
CA (1) CA2414480A1 (no)
DE (1) DE60118198T2 (no)
ES (1) ES2261441T3 (no)
HK (1) HK1057473A1 (no)
MX (1) MXPA02012944A (no)
NO (2) NO20003591L (no)
NZ (1) NZ523316A (no)
RU (1) RU2283105C2 (no)
WO (1) WO2002003983A1 (no)
ZA (1) ZA200210028B (no)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2275140A2 (en) 2004-07-19 2011-01-19 Thia Medica AS Composition comprising plant and/or fish oils and non-oxidizable fatty acid entities
WO2014140934A2 (en) 2013-03-11 2014-09-18 Life Science Nutrition As Natural lipids containing non-oxidizable fatty acids

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO328803B1 (no) 2000-03-03 2010-05-18 Thia Medica Nye fettsyreanaloger
KR20050061400A (ko) 2002-06-20 2005-06-22 아이씨 벡 리미티드 황-함유 인지질 유도체
NO20053519L (no) * 2005-07-18 2007-01-19 Thia Medica As Anvendelse av forbindelser som omfatter fettsyrer
US8986253B2 (en) 2008-01-25 2015-03-24 Tandem Diabetes Care, Inc. Two chamber pumps and related methods
US8408421B2 (en) 2008-09-16 2013-04-02 Tandem Diabetes Care, Inc. Flow regulating stopcocks and related methods
EP2334234A4 (en) 2008-09-19 2013-03-20 Tandem Diabetes Care Inc DEVICE FOR MEASURING THE CONCENTRATION OF A SOLVED SUBSTANCE AND CORRESPONDING METHOD
EP2932994B1 (en) 2009-07-30 2017-11-08 Tandem Diabetes Care, Inc. New o-ring seal, and delivery mechanism and portable infusion pump system related thereto
US9180242B2 (en) 2012-05-17 2015-11-10 Tandem Diabetes Care, Inc. Methods and devices for multiple fluid transfer
US9555186B2 (en) 2012-06-05 2017-01-31 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
CA2904898C (en) 2013-03-11 2019-10-15 Jan Remmereit Lipid compositions containing bioactive fatty acids
US9173998B2 (en) 2013-03-14 2015-11-03 Tandem Diabetes Care, Inc. System and method for detecting occlusions in an infusion pump
DE102014116958B9 (de) * 2014-11-19 2017-10-05 Trumpf Laser- Und Systemtechnik Gmbh Optisches System zur Strahlformung eines Laserstrahls, Laserbearbeitungsanlage, Verfahren zur Materialbearbeitung und Verwenden einer gemeinsamen langgezogenen Fokuszone zur Lasermaterialbearbeitung
JP2018519278A (ja) * 2015-06-11 2018-07-19 ユニバーシティー オブ マイアミＵｎｉｖｅｒｓｉｔｙ Ｏｆ Ｍｉａｍｉ 癌の治療及び診断
CN105498622B (zh) * 2015-12-10 2017-10-17 江南大学 一种含硒表面活性剂及其制备方法和应用
CN107235880B (zh) * 2017-06-30 2018-10-30 江南大学 一种含硒阳离子表面活性剂及其应用
GB201910644D0 (en) * 2019-07-25 2019-09-11 Coegin Pharma As Cancer Treatment
US11897888B1 (en) 2020-04-30 2024-02-13 Stinginn Llc Small molecular inhibitors of sting signaling compositions and methods of use
CN115260964A (zh) * 2022-08-29 2022-11-01 烟台市福山义昌精细化工厂 一种石油油管丝扣专用密封胶及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0686377B2 (ja) * 1985-09-30 1994-11-02 日清製粉株式会社 がん転移抑制剤
JPH0797320A (ja) * 1993-08-04 1995-04-11 Takuma Sasaki 制癌剤
US6358915B1 (en) * 1995-03-07 2002-03-19 George Washington University Methods for inhibiting metastasis
DK0768084T3 (da) * 1995-04-10 2002-10-14 Taiho Pharmaceutical Co Ltd Kræftmetastaseinhibitor
NO952796D0 (no) * 1995-07-14 1995-07-14 Rolf Berge Fettsyre analoger med ikkeoksyderbart B-sete, fremstilling og anvendelse i krapeutiske preparater
AU7240398A (en) * 1998-05-08 1999-11-29 Rolf Berge Use of non-beta-oxidizable fatty acid analogues for treatment of syndrome-x conditions
JP4993878B2 (ja) * 2005-06-28 2012-08-08 ダイキョーニシカワ株式会社 多気筒エンジンの吸気装置

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2275140A2 (en) 2004-07-19 2011-01-19 Thia Medica AS Composition comprising plant and/or fish oils and non-oxidizable fatty acid entities
WO2014140934A2 (en) 2013-03-11 2014-09-18 Life Science Nutrition As Natural lipids containing non-oxidizable fatty acids

Also Published As

Publication number Publication date
RU2283105C2 (ru) 2006-09-10
JP2004502732A (ja) 2004-01-29
CN100569228C (zh) 2009-12-16
WO2002003983A1 (en) 2002-01-17
US20040024063A1 (en) 2004-02-05
US7378443B2 (en) 2008-05-27
NO20003591L (no) 2002-01-14
BR0112399A (pt) 2003-05-27
DE60118198D1 (de) 2006-05-11
CA2414480A1 (en) 2002-01-17
KR20080071598A (ko) 2008-08-04
NZ523316A (en) 2004-09-24
CN1441671A (zh) 2003-09-10
AU7286001A (en) 2002-01-21
AU2001272860B2 (en) 2005-11-24
ES2261441T3 (es) 2006-11-16
ATE320802T1 (de) 2006-04-15
NO20003591D0 (no) 2000-07-13
NO20025930D0 (no) 2002-12-11
NO324634B1 (no) 2007-11-26
EP1313463A1 (en) 2003-05-28
HK1057473A1 (en) 2004-04-08
KR100861428B1 (ko) 2008-10-02
DE60118198T2 (de) 2007-01-25
MXPA02012944A (es) 2004-05-17
ZA200210028B (en) 2004-01-26
EP1313463B1 (en) 2006-03-22
KR20030016399A (ko) 2003-02-26

Similar Documents

Publication Publication Date Title
NO20025930D0 (no) Fettsyreanaloger for behandling av cancer
MX9804105A (es) Antagonistas de taquicininas a base de piperidonas.
DK1075260T3 (da) Hidtil ukendte fedtsyreanaloger til behandling af sekundær restenose
BRPI0518068A (pt) composto ou um éster ou sal farmaceuticamente aceitável do mesmo, composição farmacêutica, inibidor seletivo de aurora a, agente anti-tumor, e, preparação combinada
BR9912036A (pt) Composições de filtro solar
ES2193874A1 (es) Compuestos naturales y derivados de estos para la prevencion y el tratamiento de enfermedades cardiovasculares, hepaticas, renales y cosmeticas.
KR960705810A (ko) 퀴나졸린 유도체(quinazoline derivatives)
RU2002134754A (ru) Аналоги жирных кислот для лечения рака
MY141869A (en) Mouth rinse compositions
JP2004502732A5 (no)
NO20004844L (no) Fettsyre analoger for behandling av proliferative hudsykdommer
EE200000472A (et) Kasvajavastased toimeained
DE69839781D1 (en) Heterocyclische topoisomerase toxine
MY129176A (en) Tetrahydro gamma-carbolines
TW200724131A (en) Antibacterial 5,5'-disubstituted 3,3'-dialkoxy-2,2'-dihydroxy-1,1'-biphenyl compounds and related methods
NO20014240D0 (no) C16-umettede FP-selektive prostaglandinanaloger
TW200505438A (en) Method of treating cancer with azaspirane compositions
DE60308171D1 (de) Haarpflegemittel, die phenolische haarformungsmittel enthalten
NO20023041D0 (no) Fremgangsmåte for fremstilling av pyrazolopyridazinderivater
TR200100070A2 (tr) Bileşim
KR950008515A (ko) 피리도[1,2,3-d,e][1,3,4] 벤족사디아진 유도체
HUP0301561A2 (hu) Triazintrion-szulfoxidok alkalmazása kokcidiózis elleni készítmények elżállítására
JPS5622732A (en) Antitumor agent composed mainly of organic silicon compound

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees